Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03771443Phase 3Completed
Phase 3, open-label, single-arm trial in celiac disease, sponsored by Cairo University. Primary endpoint: Ulcerative events at 6 months. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03771443.